Laboratorios Farmaceuticos (Spain) Probability of Future Stock Price Finishing Under 63.05

ROVI Stock  EUR 64.45  0.60  0.94%   
Laboratorios Farmaceuticos' future price is the expected price of Laboratorios Farmaceuticos instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Laboratorios Farmaceuticos ROVI performance during a given time horizon utilizing its historical volatility. Check out Laboratorios Farmaceuticos Backtesting, Laboratorios Farmaceuticos Valuation, Laboratorios Farmaceuticos Correlation, Laboratorios Farmaceuticos Hype Analysis, Laboratorios Farmaceuticos Volatility, Laboratorios Farmaceuticos History as well as Laboratorios Farmaceuticos Performance.
  
Please specify Laboratorios Farmaceuticos' target price for which you would like Laboratorios Farmaceuticos odds to be computed.

Laboratorios Farmaceuticos Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Laboratorios Farmaceuticos for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Laboratorios Farmaceuticos can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Laboratorios Farmaceuticos generated a negative expected return over the last 90 days
About 60.0% of the company outstanding shares are owned by corporate insiders

Laboratorios Farmaceuticos Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Laboratorios Stock often depends not only on the future outlook of the current and potential Laboratorios Farmaceuticos' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Laboratorios Farmaceuticos' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding55.4 M
Cash And Short Term Investments99 M

Laboratorios Farmaceuticos Technical Analysis

Laboratorios Farmaceuticos' future price can be derived by breaking down and analyzing its technical indicators over time. Laboratorios Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Laboratorios Farmaceuticos ROVI. In general, you should focus on analyzing Laboratorios Stock price patterns and their correlations with different microeconomic environments and drivers.

Laboratorios Farmaceuticos Predictive Forecast Models

Laboratorios Farmaceuticos' time-series forecasting models is one of many Laboratorios Farmaceuticos' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Laboratorios Farmaceuticos' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Laboratorios Farmaceuticos

Checking the ongoing alerts about Laboratorios Farmaceuticos for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Laboratorios Farmaceuticos help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Laboratorios Farmaceuticos generated a negative expected return over the last 90 days
About 60.0% of the company outstanding shares are owned by corporate insiders

Other Information on Investing in Laboratorios Stock

Laboratorios Farmaceuticos financial ratios help investors to determine whether Laboratorios Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Laboratorios with respect to the benefits of owning Laboratorios Farmaceuticos security.